Larissa V Rodríguez1, Alisa J Stephens2, J Quentin Clemens3, Dedra Buchwald4, Claire Yang4, Henry H Lai5, John N Krieger4, Craig Newcomb2, Cate S Bradley6, Bruce Naliboff7. 1. Departments of Urology and Obstetrics and Gynecology, Institute of Urology, University of Southern California, Los Angeles, CA. Electronic address: lrodriguez@med.usc.edu. 2. Data Coordinating Core, Department of Biostatistics and Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA. 3. Department of Urology, University of Michigan Medical Center, Ann Arbor, MI. 4. Department of Urology, University of Washington, Seattle, WA. 5. Departments of Surgery (Division of Urologic Surgery) and Anesthesiology, Washington University, St. Louis, MO. 6. Department of Obstetrics and Gynecology, and Urology, College of Medicine and Department of Public Epidemiology, College of Public Health, University of Iowa, Iowa City, IA. 7. Departments of Medicine and Psychiatry, The Geffen School of Medicine at UCLA, Los Angeles, CA.
Abstract
OBJECTIVE: To evaluate if patients with urologic chronic pelvic pain syndromes (UCPPS) with longer duration of symptoms experience more severe pain and urologic symptoms, higher rates of chronic overlapping pain conditions (COPC) and psychosocial comorbidities than those with a more recent onset of the condition. We evaluated cross-sectional associations between UCPPS symptom duration and (1) symptom severity, (2) presence of COPC, and (3) mental health comorbidities. METHODS: We analyzed baseline data from the Multidisciplinary Approach to the Study of Chronic Pelvic Pain. Symptom severity, COPC, and mental health comorbidities were compared between patients with symptom duration of < 2 vs ≥ 2 years. Symptom severity was assessed by the Genitourinary Pain Index, the Interstitial Cystitis Symptom and Problem Index, and Likert scales for pelvic pain, urgency, and frequency. Depression and anxiety were evaluated with the Hospital Anxiety and Depression Scale and stress with the Perceived Stress Scale. RESULTS: Males (but not females) with UCPPS symptom duration ≥2 years had more severe symptoms than those with <2 years. Participants with short (<2 years) and longer (≥2 years) symptom duration were as likely to experience COPC. CONCLUSION: Longer UCPPS symptom duration was associated with more severe symptoms only in limited patient subpopulations. Symptom duration was not associated with risk for COPC or mental health comorbidities. Females with longer UCPPS duration had decreased distress, but the association was largely attributable to age.
OBJECTIVE: To evaluate if patients with urologic chronicpelvic pain syndromes (UCPPS) with longer duration of symptoms experience more severe pain and urologic symptoms, higher rates of chronic overlapping pain conditions (COPC) and psychosocial comorbidities than those with a more recent onset of the condition. We evaluated cross-sectional associations between UCPPS symptom duration and (1) symptom severity, (2) presence of COPC, and (3) mental health comorbidities. METHODS: We analyzed baseline data from the Multidisciplinary Approach to the Study of Chronic Pelvic Pain. Symptom severity, COPC, and mental health comorbidities were compared between patients with symptom duration of < 2 vs ≥ 2 years. Symptom severity was assessed by the Genitourinary Pain Index, the Interstitial Cystitis Symptom and Problem Index, and Likert scales for pelvic pain, urgency, and frequency. Depression and anxiety were evaluated with the Hospital Anxiety and Depression Scale and stress with the Perceived Stress Scale. RESULTS: Males (but not females) with UCPPS symptom duration ≥2 years had more severe symptoms than those with <2 years. Participants with short (<2 years) and longer (≥2 years) symptom duration were as likely to experience COPC. CONCLUSION: Longer UCPPS symptom duration was associated with more severe symptoms only in limited patient subpopulations. Symptom duration was not associated with risk for COPC or mental health comorbidities. Females with longer UCPPS duration had decreased distress, but the association was largely attributable to age.
Authors: H Henry Lai; John N Krieger; Michel A Pontari; Dedra Buchwald; Xiaoling Hou; J Richard Landis Journal: J Urol Date: 2015-07-17 Impact factor: 7.450
Authors: J Quentin Clemens; Talar W Markossian; Richard T Meenan; Maureen C O'Keeffe Rosetti; Elizabeth A Calhoun Journal: J Urol Date: 2007-08-16 Impact factor: 7.450
Authors: J Quentin Clemens; Elizabeth A Calhoun; Mark S Litwin; Mary McNaughton-Collins; John W Kusek; Evelyn M Crowley; J Richard Landis Journal: Urology Date: 2009-10-02 Impact factor: 2.649
Authors: Simon M Collin; Stephanie Nikolaus; Jon Heron; Hans Knoop; Peter D White; Esther Crawley Journal: J Psychosom Res Date: 2015-12-23 Impact factor: 3.006
Authors: Henry Lai; Emine O Bayman; Michael O Bishop; Richard Landis; Steven E Harte; Quentin Clemens; Larissa V Rodriguez; Siobhan Sutcliffe; Bayley J Taple; Bruce D Naliboff Journal: Urology Date: 2022-01-10 Impact factor: 2.633